Hypertension Risk Among Cancer Patients Treated With Sunitinib: A Meta-analysis and Systematic Review
Published: | Updated:
Sunitinib treatment is associated with a significantly increased risk of all-grade and high-grade hypertension.
Sungyub Lew, MD
Articles by Sungyub Lew, MD
Latest Updated Articles
Hypertension Risk Among Cancer Patients Treated With Sunitinib: A Meta-analysis and Systematic ReviewPublished: June 27th 2015 | Updated: April 18th 2020